INS and fatty liver disease: Elevated levels of LEAP-2 were found in mice and humans with liver steatosis and showed a positive correlation with fasting insulin, Homeostatic Model Assessment of Insulin Resistance, and liver fat content related to glucolipid metabolism [26].